Air Liquide UK has completed an investment of over ¤3 million in the redevelopment of its filling and production facilities in Stoke on Trent, UK.
Air Liquide UK has completed an investment of over €3 million in the redevelopment of its filling and production facilities in Stoke on Trent, UK. Following the recent acquisition of Scott Specialty Gases, the company will consolidate its speciality gas operations into a Stoke on Trent-based centre of excellence that will be totally dedicated to production, filling and supply. The facility incorporates the company’s new proprietary fill system for the manufacture of calibration mixtures with the assurance of quality and safety. This is complimented by the Acublend filling system, which is dedicated to providing mixtures with repeatability for emissions testing markets.
“Air Liquide UK continues to prove its ongoing commitment to listen to its customers and develop its business infrastructure with major investments to meet customer and market needs”, said Sylvie Villepontoux, managing director for the company.
This investment is expected to deliver a wider and more comprehensive product range. Shorter manufacturing lead times will be supported by an enhanced service offer for the UK market alongside access to worldwide expertise specific to speciality gases applications across environment, industry, universities, science and research.
For more information visit www.uk.airliquide.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.